Vertex Pharmaceuticals Incorporated Equity-NMS: VRTX

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$484.01
Open :$484.35
Today's high :$499.07
Today's low :$473.64
52W low :$377.85
52W high :$519.88
EPS(TTM): :-2.08
Shares O/S :256.79 M
Market cap :121.88 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Vertex Pharmaceuticals Incorporated $474.62 -54.64% - 121.88B

Frequently Asked Questions

What is the share price of Vertex Pharmaceuticals Incorporated today?

Vertex Pharmaceuticals Incorporated (VRTX) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes clinical-stage programs in CF, SCD, beta thalassemia, acute and peripheral neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy and other autoimmune renal diseases and cytopenias, type 1 diabetes, myotonic dystrophy type 1, and autosomal dominant polycystic kidney disease. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (elexacaftor/tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor).